Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Non-cash Items: 2015-2024

Historic Non-cash Items for Assembly Biosciences (ASMB) over the last 4 years, with Dec 2024 value amounting to $517,237.

  • Assembly Biosciences' Non-cash Items rose 51623.70% to $517,237 in Q4 2024 from the same period last year, while for Dec 2024 it was $517,237, marking a year-over-year increase of 51623.70%. This contributed to the annual value of $1.4 million for FY2024, which is 138200.00% up from last year.
  • Per Assembly Biosciences' latest filing, its Non-cash Items stood at $517,237 for Q4 2024, which was up 51,623.70% from $1,000 recorded in Q4 2023.
  • In the past 5 years, Assembly Biosciences' Non-cash Items ranged from a high of $63.2 million in Q2 2020 and a low of $1,000 during Q4 2023.
  • Over the past 3 years, Assembly Biosciences' median Non-cash Items value was $517,237 (recorded in 2024), while the average stood at $1.8 million.
  • Per our database at Business Quant, Assembly Biosciences' Non-cash Items tumbled by 99.86% in 2022 and then soared by 51,623.70% in 2024.
  • Quarterly analysis of 5 years shows Assembly Biosciences' Non-cash Items stood at $1.9 million in 2020, then tumbled by 97.14% to $53,000 in 2021, then increased by 12.07% to $4.2 million in 2022, then reached $1,000 in 2023, then surged by 51,623.70% to $517,237 in 2024.
  • Its last three reported values are $517,237 in Q4 2024, $1,000 for Q4 2023, and $4.2 million during Q3 2022.